Cargando…
LC16m8: An attenuated smallpox vaccine
The frequency of moderate to severe adverse reactions associated with smallpox vaccines currently stockpiled in the US, and the continued threat of bioterrorism have prompted the development of effective vaccines with improved safety profiles. LC16m8, an attenuated, replicating smallpox vaccine deri...
Autores principales: | Kenner, Julie, Cameron, Fiona, Empig, Cyril, Jobes, David V., Gurwith, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115618/ https://www.ncbi.nlm.nih.gov/pubmed/17052815 http://dx.doi.org/10.1016/j.vaccine.2006.03.087 |
Ejemplares similares
-
Serological responses in humans to the smallpox vaccine LC16m8
por: Johnson, Benjamin F., et al.
Publicado: (2011) -
Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8
por: Eto, Akiko, et al.
Publicado: (2015) -
A replication-competent smallpox vaccine LC16m8Δ-based COVID-19 vaccine
por: Sakamoto, Akihiko, et al.
Publicado: (2022) -
An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox
por: Tomita, Noriko, et al.
Publicado: (2023) -
A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome
por: Yoshikawa, Tomoki, et al.
Publicado: (2021)